---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-045015"
form_type: "8-K"
ticker: "HYPD"
cik: "0001682639"
company_name: "HYPERION DEFI, INC."
filed_at: "2024-04-09T23:59:59+00:00"
generated_at: "2026-06-04T00:59:30.333736+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Eyenovia raises ~$2.0M in registered direct offering at $0.6204/share

## Summary
- Sold 3,223,726 shares at $0.6204/share to a single healthcare investor; gross proceeds ~$2.0M.
- Net proceeds to fund commercialization of Mydcombi and clobetasol propionate, complete CHAPERONE study.
- Offering expected to close on or about April 11, 2024, subject to customary conditions.
- Shares issued under existing effective shelf registration statement (No. 333-261638).

## SEC filing metadata
- accession: 0001104659-24-045015
- form_type: 8-K
- ticker: HYPD
- cik: 0001682639
- company_name: HYPERION DEFI, INC.
- filed_at: 2024-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682639/000110465924045015/0001104659-24-045015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682639/000110465924045015/tm2411385d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-045015
- JSON: https://secwatch.observer/filing/0001104659-24-045015.json
- Plain text: https://secwatch.observer/filing/0001104659-24-045015.txt

## Key facts
- Material Agreements
  HYPERION DEFI, INC. entered into Purchase Agreement with a single fundamentals-based healthcare investor valued at approximately $2.0 million (effective 2024-04-08).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a single fundamentals-based healthcare investor
  - Value: approximately $2.0 million
  - Effective: 2024-04-08
  source text: On April 8, 2024, Eyenovia, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a single fundamentals-based healthcare investor (the “Purchaser”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682639/000110465924045015/0001104659-24-045015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.